In early 2023, the Ontario government took a significant step to expand the role of pharmacists in healthcare by allowing them to prescribe medication for 13 common ailments, including hay fever and acid reflux. This initiative, part of Premier Doug Ford's health reforms, includes compensating pharmacists with an assessment fee for consultations, thus enhancing their role in the primary healthcare system. The move aims to alleviate pressure on doctors and streamline access to care for patients with minor health issues.

Several months after the implementation of this new policy, Health Minister Sylvia Jones held a meeting with Jeff Leger, the then-president of Shoppers Drug Mart. The purpose of the meeting, as indicated in an internal briefing note obtained through freedom of information requests, was reported to be focused on collaborative efforts to improve the provincial primary care system. However, discrepancies in the narratives provided by the Health Minister's office and Loblaw, the parent company of Shoppers Drug Mart, have raised questions about the actual topics of discussion during their encounter.

The conflicting accounts and focus of the meeting underscore the ongoing tensions between government efforts to reform health care and private entities' interests in shaping these policies. There is a growing debate over the degree to which pharmacists should be involved in prescribing medications, as well as the broader implications for healthcare accessibility in Ontario as the province seeks to optimize its primary care resources. This development could signal a significant shift in how health services are delivered, with business interests playing a potentially pivotal role in shaping public health policy.